HOME >> MEDICINE >> NEWS
USC researchers show that molecular markers predict tumor recurrence

Chicago, Il., June 5, 2007 -- Researchers at the University of Southern California (USC) have identified specific molecular markers that may help to predict tumor recurrence in stage II and III colon cancer patients.

The findings may also help identify stage II colon cancer patients who are more likely to benefit from adjuvant chemotherapy following surgery, says Georg Lurje M.D., research associate at the Keck School of Medicine of the University of Southern California (USC).

The study was presented Tuesday, June 5 at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO) held at McCormick Place in Chicago.

For patients who undergo surgery for stage III colon cancerin which the tumor has spread to the lymph nodesadditional chemotherapy is recommended to prevent tumor recurrence, Lurje says. While surgery alone is usually effective for treating stage II cancer, 20 to 30 percent of patients do develop tumor recurrence and die from the disease, he says.

This study is the very first to demonstrate that genes in the angiogenesis pathway play a critical role in tumor relapse, says Heinz-Josef Lenz, M.D., professor of medicine at the Keck School and the principal investigator on the study. These molecular markers not only help us to identify patients who are at high risk, but they may be critical to selecting the most efficient therapy.

Angiogenesis refers to the blood vessel formation that provides nutrients and oxygen to cancerous growths. Researchers analyzed blood specimens that were obtained at USC medical facilities between 1999 and 2007, testing whether a specific pattern of polymorphisms in 33 genes involved in cancer progression predicted tumor recurrence. Of the 197 patients who participated, 72 patients had stage II and 125 had stage III colon cancer.

Researchers identified the vascular endothelial growth factor protein (VEGF) and its receptor VEGFR-2 as one of the most importa
'"/>

Contact: Meghan Lewit
lewit@usc.edu
323-442-2830
University of Southern California
5-Jun-2007


Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
3. Penn researchers discover novel pathway for increasing good cholesterol
4. Theory of facial aging gets a facelift from UT Southwestern researchers
5. UIC researchers to develop new drugs to fight bioterrorism
6. UQ researchers discover some of the oldest forms of life
7. U of M researchers discover new method to combat HIV
8. U of M researchers assess effectiveness of computerized physician order entry system
9. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
10. Physician-researchers often less successful in obtaining NIH funding
11. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... September 01, 2020 , ... Board certified ... Glendale. While the office will be the first to bear her name, Dr. ... augmentation (Brazilian butt lift), as well as rhinoplasty, facial rejuvenation, and many more ...
(Date:8/31/2020)... ... 2020 , ... Cardiothoracic surgeons at Allegheny General Hospital (AGH), ... University (CMU) to develop a new heart monitoring device designed to serve as ... The AGH/CMU team was recently awarded a “Trailblazer” grant from the National Institutes ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... business management solution for chiropractors, announced today the launch of its integrated, HIPAA ... can start running their virtual practice in under 90 seconds. , According ...
(Date:8/31/2020)... ... ... In an effort to give back to the community in which it serves, ... booked with a special new rate code to benefit children and families at ... Donations will be applied to any room type, any time, now through the end ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... ... assist system designed to help treat patients with respiratory conditions, including COVID-19, while ... of helium and oxygen, but it captures exhaled gas and scrubs it free ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Using Analysis of Variance — ... Sept. 17, 2020, 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/anova , How much would ... , While one can’t become one in 90 minutes, one can master a powerful ...
(Date:9/2/2020)... ... September 02, 2020 , ... ... will moderate a roundtable discussion among industry professionals about successes and challenges of ... by American Pharmaceutical Review and will take place on October 15, ...
(Date:9/2/2020)... ... September 02, 2020 , ... U.S. Dermatology Partners is excited ... Lee will work at Bethesda Dermatopathology Lab. , Jonathan Lee, MD grew ... of California, Berkley. He went on to receive his M.D. with Honors from Harvard ...
Breaking Medicine Technology:
Cached News: